309 related articles for article (PubMed ID: 20502000)
1. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.
Kornhuber J; Tripal P; Reichel M; Mühle C; Rhein C; Muehlbacher M; Groemer TW; Gulbins E
Cell Physiol Biochem; 2010; 26(1):9-20. PubMed ID: 20502000
[TBL] [Abstract][Full Text] [Related]
2. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.
Rhein C; Löber S; Gmeiner P; Gulbins E; Tripal P; Kornhuber J
J Neural Transm (Vienna); 2018 Dec; 125(12):1837-1845. PubMed ID: 30191367
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel functional inhibitors of acid sphingomyelinase.
Kornhuber J; Muehlbacher M; Trapp S; Pechmann S; Friedl A; Reichel M; Mühle C; Terfloth L; Groemer TW; Spitzer GM; Liedl KR; Gulbins E; Tripal P
PLoS One; 2011; 6(8):e23852. PubMed ID: 21909365
[TBL] [Abstract][Full Text] [Related]
4. Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2.
Pauletto PJT; Delgado CP; da Rocha JBT
Cell Biochem Funct; 2023 Apr; 41(3):284-295. PubMed ID: 36929117
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
He X; Schuchman EH
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
[TBL] [Abstract][Full Text] [Related]
6. The acid sphingomyelinase/ceramide system in COVID-19.
Kornhuber J; Hoertel N; Gulbins E
Mol Psychiatry; 2022 Jan; 27(1):307-314. PubMed ID: 34608263
[TBL] [Abstract][Full Text] [Related]
7. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
9. Functional inhibitors of acid sphingomyelinase (FIASMAs).
Kornhuber J; Tripal P; Gulbins E; Muehlbacher M
Handb Exp Pharmacol; 2013; (215):169-86. PubMed ID: 23579455
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro.
Naser E; Kadow S; Schumacher F; Mohamed ZH; Kappe C; Hessler G; Pollmeier B; Kleuser B; Arenz C; Becker KA; Gulbins E; Carpinteiro A
J Lipid Res; 2020 Jun; 61(6):896-910. PubMed ID: 32156719
[TBL] [Abstract][Full Text] [Related]
11. Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens.
Cockburn CL; Green RS; Damle SR; Martin RK; Ghahrai NN; Colonne PM; Fullerton MS; Conrad DH; Chalfant CE; Voth DE; Rucks EA; Gilk SD; Carlyon JA
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30902833
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression.
Rhein C; Reichel M; Kramer M; Rotter A; Lenz B; Mühle C; Gulbins E; Kornhuber J
J Affect Disord; 2017 Feb; 209():10-15. PubMed ID: 27866044
[TBL] [Abstract][Full Text] [Related]
13. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.
Beckmann N; Becker KA; Kadow S; Schumacher F; Kramer M; Kühn C; Schulz-Schaeffer WJ; Edwards MJ; Kleuser B; Gulbins E; Carpinteiro A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835809
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.
Taniguchi M; Ogiso H; Takeuchi T; Kitatani K; Umehara H; Okazaki T
Cell Death Dis; 2015 Apr; 6(4):e1717. PubMed ID: 25855965
[TBL] [Abstract][Full Text] [Related]
15. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
16. Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway.
Perry DM; Newcomb B; Adada M; Wu BX; Roddy P; Kitatani K; Siskind L; Obeid LM; Hannun YA
J Biol Chem; 2014 Aug; 289(32):22401-12. PubMed ID: 24951586
[TBL] [Abstract][Full Text] [Related]
17. Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study.
Hoertel N; Sánchez-Rico M; Gulbins E; Kornhuber J; Carpinteiro A; Lenze EJ; Reiersen AM; Abellán M; de la Muela P; Vernet R; Blanco C; Cougoule C; Beeker N; Neuraz A; Gorwood P; Alvarado JM; Meneton P; Limosin F;
Clin Pharmacol Ther; 2021 Dec; 110(6):1498-1511. PubMed ID: 34050932
[TBL] [Abstract][Full Text] [Related]
18. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Kornhuber J; Tripal P; Reichel M; Terfloth L; Bleich S; Wiltfang J; Gulbins E
J Med Chem; 2008 Jan; 51(2):219-37. PubMed ID: 18027916
[TBL] [Abstract][Full Text] [Related]
19. Acid Sphingomyelinase Mediates Oxidized-LDL Induced Apoptosis in Macrophage via Endoplasmic Reticulum Stress.
Zhao M; Pan W; Shi RZ; Bai YP; You BY; Zhang K; Fu QM; Schuchman EH; He XX; Zhang GG
J Atheroscler Thromb; 2016 Sep; 23(9):1111-25. PubMed ID: 26923251
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy.
Justice MJ; Bronova I; Schweitzer KS; Poirier C; Blum JS; Berdyshev EV; Petrache I
J Lipid Res; 2018 Apr; 59(4):596-606. PubMed ID: 29378782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
